Most men with erectile dysfunction remain untreated, scientists say

March 19, 2013

Despite the high erectile dysfunction (ED) prevalence most patients receive no treatment, according to a new US study, presented at the 28th Annual EAU Congress. Undertreatment of ED continues to be common, even though the treatments have a proven efficacy and quality of life impact.

"Until now, research conducted on the treatment of erectile dysfunction has been derived from surveys involving small populations," wrote the authors.

"However, a comprehensive and larger patient-based study using claims data that characterises men undergoing treatment for ED remains to be performed. The aim of the study was to determine the frequency of use of medical therapies, associated co-morbidites of ED in a large of men."

During a 12-month period ending June 2011, patients were identified and included in a payor data-set if they received a diagnosis code for ED. Patients were considered "treated" if they filled a prescription for a phosphodiesterase type 5 inhibitor (PDE5i), injection or urethral or androgen replacement (ART). "Untreated" patients received the diagnosis but did not fill a prescription.

The therapies prescribed were monitored by prescription frequency prescribed, age, co-morbidities, and by physician speciality.

Of the 6,228,509 patients derived from a pool of 87,600,000 men with a diagnosis of ED, 25.4% of these were treated; 74.6% went untreated. The most commonly prescribed medications were PDE5i (75.2%) and ART (30.6%).

Less than 2% of patients used any prostaglandin therapy. Treatment frequency was higher for co-morbid (51% treated) and less for co-morbid (15% treated), but otherwise it did not vary significantly with other associated comorbidities.

Explore further: Sexual health of men with chronic heart failure significantly improves with CRT

Related Stories

Erectile dysfunction prevalence higher in HIV-infected men

July 12, 2012

(HealthDay) -- HIV infection in men is a strong, independent predictor of erectile dysfunction (ED), regardless of age and body mass index (BMI), according to a study published in the July issue of The Journal of Sexual Medicine.

Predicting erectile dysfunction from prostate cancer treatment

September 27, 2012

Researchers have identified 12 DNA sequences that may help doctors determine which men will suffer from erectile dysfunction (ED) following radiation therapy for prostate cancer. Identifying these patients in advance of treatment ...

Managing erectile dysfunction, comorbid diseases linked

December 3, 2012

(HealthDay)—Diagnosis and management of erectile dysfunction (ED) improves health outcomes for men with comorbid diseases, and vice versa, according to research published online Nov. 15 in The Journal of Sexual Medicine.

Recommended for you

Ebola virus mutations may help it evade drug treatment

September 11, 2015

Genetic mutations called "escape variants" in the deadly Ebola virus appear to block the ability of antibody-based treatments to ward off infection, according to a team of U.S. Army scientists and collaborators. Their findings, ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.